Arran Attridge

Bio:

Arran Attridge serves as Chief Corporate Affairs Officer at 2Vie Therapies and acts as a fractional head of communications and advisor to emerging biotech organizations. She focuses on building positive reputation and trust across key stakeholders to support long-term business strategy.Arran has more than two decades of experience as a public relations and advocacy leader, guiding corporate and product communications strategy through pre-clinical and clinical development, regulatory review, launch and in-market access across a range of therapeutic areas. Arran's prior roles include SVP at Vir Biotechnology and VP at CymaBay Therapeutics, which was acquired by Gilead Sciences for $4.3bn. There she led corporate communications in preparation for commercialization and through the acquisition of the company. Prior to that, Arran served over a decade at Gilead Sciences where she held roles of increasing responsibility in the U.S. and Europe across a range of therapeutic areas. Prior to joining pharma and biotech inhouse, Arran was a public relations consultant in the U.K. with a focus on corporate reputation, advocacy and product commercialization.